legacy 发表于 2025-3-25 03:44:26

http://reply.papertrans.cn/63/6231/623062/623062_21.png

inundate 发表于 2025-3-25 08:37:41

http://reply.papertrans.cn/63/6231/623062/623062_22.png

Aboveboard 发表于 2025-3-25 12:47:07

http://reply.papertrans.cn/63/6231/623062/623062_23.png

鄙视 发表于 2025-3-25 19:22:31

http://reply.papertrans.cn/63/6231/623062/623062_24.png

LUCY 发表于 2025-3-25 23:22:38

Endocrine, and includes hypophysitis, thyroid dysfunction, insulin-deficient diabetes, and adrenal insufficiency. Diagnosis can be challenging as onset is variable and patients can have damage to more than one organ. However, if diagnosed appropriately and treated in a timely manner, the patients can continue

genesis 发表于 2025-3-26 02:47:01

Gastroenterology (GI),of these immunotherapeutic agents comes with the risk of toxicities, namely, immune-related adverse events (irAEs). Toxicities involving the gastrointestinal (GI) tract are frequent and vary in severity from mild disease to aggressive life-threatening clinical presentations. Timely clinical, biochem

BURSA 发表于 2025-3-26 06:24:35

Hematology,. This type of treatment has shown beneficial and clinically meaningful effectiveness against many types of cancers, such as melanoma; kidney, lung, and bladder cancers; and lymphomas [.]. ICIs target suppression receptors such as programmed cell death protein 1 (PD-1) and cytotoxic T lymphocyte ant

FLING 发表于 2025-3-26 08:59:57

http://reply.papertrans.cn/63/6231/623062/623062_28.png

Flat-Feet 发表于 2025-3-26 13:20:42

http://reply.papertrans.cn/63/6231/623062/623062_29.png

带子 发表于 2025-3-26 16:52:37

http://reply.papertrans.cn/63/6231/623062/623062_30.png
页: 1 2 [3] 4 5 6
查看完整版本: Titlebook: Managing Immunotherapy Related Organ Toxicities; A Practical Guide Yinghong Wang Book 2022 The Editor(s) (if applicable) and The Author(s),